| RS138739620 |
HMGCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxy-3-methylglutaryl-CoA synthase deficiency, 3-hydroxy-3-methylglutaryl-CoA synthase deficiency |
| RS1387399556 |
DYNC1H1
|
Health Risk |
Pathogenic |
— |
| RS138740193 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, PDGFRA-related disorder |
| RS1387402564 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS138741202 |
EIF2B3
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, EIF2B3-related disorder |
| RS138741225 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, BCOR-related disorder |
| RS138741747 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
COG8-congenital disorder of glycosylation, COG8-related disorder |
| RS1387418594 |
TULP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 15, Retinitis pigmentosa 14 |
| RS138742252 |
ELP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ELP2-related disorder |
| RS1387426259 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS138742804 |
MED23
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 18 |
| RS138743097 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1387431334 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1387431464 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138743322 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138743872 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, MYO5B-related disorder |
| RS1387442810 |
TCN2
|
Health Risk |
Likely pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS138744722 |
SLC7A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |
| RS1387448237 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS138744839 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS138745073 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 76, Muscle eye brain disease |
| RS1387453473 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy |
| RS138745459 |
DZIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1387456031 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS138745849 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1387460227 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1387462152 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138746296 |
MTMR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS138746304 |
FUS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 6 |
| RS1387467529 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS138747073 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS1387479871 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS138748289 |
POLE
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Facial dysmorphism-immunodeficiency-livedo-short stature syndrome |
| RS138748613 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, LAMB3-related disorder |
| RS138749562 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS1387498138 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS138749826 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS138749920 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS1387503550 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS138750421 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myopathy |
| RS1387507346 |
LOX
|
Health Risk |
Pathogenic |
— |
| RS138750878 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT2-related disorder, FAT2-related disorder |
| RS138751097 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS138751215 |
GHRHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated growth hormone deficiency type IB, Inborn genetic diseases |
| RS1387516050 |
EPM2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Lafora disease |
| RS138752449 |
PHKA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXd, Inborn genetic diseases |
| RS1387536593 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1387537859 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS138753870 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS138754006 |
PTPN23
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity |
| RS138754148 |
CANT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS138754417 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, A subunit |
| RS138754589 |
SETD1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138756345 |
WNT10B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138756386 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138757060 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Cardiomyopathy |
| RS138757552 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, FAH-related disorder |
| RS138758064 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS138758085 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS1387582423 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS1387584638 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS138760063 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Inborn genetic diseases |
| RS138760068 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS138760432 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS1387606271 |
NFKB1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia 3 |
| RS138761187 |
MCM8
|
Health Risk |
Pathogenic |
Premature ovarian failure 10, Premature ovarian failure 10 |
| RS1387614369 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS138761522 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1387621695 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS138762270 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 18 |
| RS138763545 |
KRIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral cavernous malformation, Inborn genetic diseases |
| RS138763605 |
PRMT7
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS138764398 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS1387656757 |
TRIM8
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis, Seizure |
| RS138766015 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
SCN3A-related disorder, SCN3A-related disorder |
| RS1387660387 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS138766042 |
LRRC56
|
Health Risk |
Conflicting classifications of pathogenicity |
LRRC56-related disorder, LRRC56-related disorder |
| RS138766213 |
PLXNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
PLXNA2-related disorder, PLXNA2-related disorder |
| RS138767348 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS138767766 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS138768414 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS138768616 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
RAI1-related disorder, RAI1-related disorder |
| RS138768918 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21 |
| RS1387689607 |
IL7R
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS138769395 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS138769892 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Greenberg dysplasia, LBR-related disorder |
| RS138770431 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS138770708 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS138771033 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS138771137 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS138771398 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome |
| RS1387716276 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS138771756 |
HPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 1 |
| RS1387721179 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1387723456 |
LAMB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pierson syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS138772928 |
EIF2B5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Inborn genetic diseases |
| RS138773278 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS138773727 |
REST
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138774384 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Congenital hypothyroidism |
| RS1387756161 |
LMBRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria and homocystinuria type cblF, Methylmalonic aciduria and homocystinuria type cblF |